Key Takeaways
- Virtual visits produced more guideline-concordant sinusitis diagnoses than in-office visits (69.1% vs 45.7%, P<.001).[1]
- Patients seen virtually received fewer unnecessary antibiotics — 68.6% were prescribed antibiotics compared to 94.3% in-office.[1]
- Telemedicine did not increase antibiotic prescribing despite the absence of a physical exam.[2]
- PCP-based telehealth was better than direct-to-consumer platforms for appropriate prescribing (28.9% vs 37.2% antibiotic rate).[3]
- 2025 AAO-HNSF guidelines now favor watchful waiting as an initial strategy, aligning well with virtual care models.[8]
Why Sinusitis Is Ideal for Telehealth
Sinusitis is the single most common reason for antibiotic prescriptions in the United States. That fact alone makes it worth examining closely — because most of those prescriptions are unnecessary. Acute sinusitis is overwhelmingly viral. Only a small fraction of cases are bacterial, and even bacterial sinusitis often resolves without antibiotics.
What makes sinusitis a strong fit for virtual care is how the diagnosis works. The IDSA criteria for acute bacterial rhinosinusitis rely on symptom patterns: symptoms persisting more than 10 days without improvement, or the "double-worsening" pattern where symptoms initially improve and then get worse again around day 5–6. These are things a patient can describe clearly on a video call. I don't need to press on your face to hear that story.
In my practice, the physical exam for uncomplicated sinusitis adds surprisingly little to the clinical picture. Tenderness over the sinuses, nasal congestion, discolored drainage — a patient can point to where the pressure is and describe what they're seeing when they blow their nose. The diagnosis is built on the timeline and pattern of symptoms, not on what I find with a penlight.
That matters because the traditional in-office visit creates pressure — both on the patient and on the physician — to "do something." When someone drives to a clinic, waits 45 minutes, and sits in an exam room, the expectation of leaving with a prescription is hard to resist. A virtual visit removes some of that pressure and creates space for the conversation that actually helps: Is this viral or bacterial? Do you need an antibiotic, or will supportive care get you through this?
The Evidence: Virtual Visits Match or Beat In-Person Care
The strongest data on telehealth sinusitis care comes from a 2019 study in Open Forum Infectious Diseases that compared 350 adults seen through the same health network — some virtually, some in the office.[1] The results surprised many in the field. Virtual visits produced guideline-concordant diagnoses 69.1% of the time, compared to just 45.7% for in-person visits (P<.001). Fewer patients seen virtually received antibiotics (68.6% vs 94.3%, P<.001). When antibiotics were prescribed in both groups, the choice of drug was equally appropriate (67.5% vs 64.8%).
That finding — that virtual visits weren't just equivalent but actually better for guideline adherence — has a plausible explanation. Telehealth platforms can embed clinical decision support directly into the visit workflow. When a physician is prompted with the IDSA diagnostic criteria on their screen, they're more likely to apply them consistently. The in-office physician is working from memory and habit, which may or may not align with current guidelines.
A larger study from Ohio State, published in The Laryngoscope in 2021, examined 5,729 acute rhinosinusitis visits — 2,075 virtual and 3,654 in-person.[2] The central question was whether telehealth would lead to more antibiotic prescribing, since physicians couldn't perform a physical exam. It did not. There was no statistically significant difference in prescribing rates between the two groups (P=.781 for otolaryngology providers).
An RCT from Einstein Healthcare Network in 2022 added further support.[5] Forty-eight patients with acute respiratory infections were randomized to telemedicine or face-to-face evaluation. Telemedicine diagnosis was non-inferior to in-person assessment. The telemedicine group actually trended toward less antibiotic prescribing (5.9% vs 17.6%), though the small sample size limits firm conclusions.
When clinical pathways are embedded into telehealth platforms, results improve even further. A 2024 pilot published in the Journal of Telemedicine and Telecare found that implementing a care bundle with EHR-integrated guidelines increased sinusitis diagnosis rates (from 3.2% to 6.2% — suggesting more accurate coding) while simultaneously decreasing antibiotic prescribing from 65% to 56% (P<.001).[7]
Antibiotic Stewardship: The Unexpected Benefit
One of the early concerns about telehealth was that it might make antibiotic overprescribing worse. Without a physical exam to confirm findings, wouldn't physicians default to prescribing "just in case"? The data tell the opposite story.
Across multiple studies, virtual visits consistently result in fewer unnecessary antibiotic prescriptions for sinusitis. The mechanism seems straightforward: when the visit is structured around symptom history rather than exam findings, physicians are more likely to recognize viral patterns and recommend watchful waiting.
Not all telehealth is equal, though. A 2024 study in JAMA Network Open examined 27,686 children and found that the type of telehealth platform matters.[3] PCP-based telehealth visits had an antibiotic prescribing rate of 28.9%, compared to 37.2% for direct-to-consumer (DTC) platforms (RR 0.78). PCP telehealth was also less likely to diagnose sinusitis in the first place (9.9% vs 15.5%, RR 0.64) — suggesting DTC platforms may be overdiagnosing the condition to justify prescriptions.
What I tell patients: the platform matters less than the physician. A board-certified physician who knows your history, who isn't incentivized to prescribe something to keep a satisfaction score high, will make better decisions than a system designed to move patients through quickly. That applies whether the visit is virtual or in-person.
Australian data published in JMIR in 2025 confirmed this pattern internationally.[4] GP registrars were less likely to prescribe antibiotics via telehealth for respiratory infections, with odds ratios of 0.62 for both sore throat and upper respiratory tract infections. Telehealth didn't just maintain the standard — it improved it.
| Study | Setting | Key Finding |
|---|---|---|
| Open Forum Infect Dis, 2019[1] | 350 adults, single network | Virtual visits: 69.1% guideline-concordant diagnosis vs 45.7% in-office (P<.001) |
| Ohio State / Laryngoscope, 2021[2] | 5,729 ARS visits | No difference in antibiotic prescribing between virtual and in-person (P=.781) |
| Einstein RCT, 2022[5] | 48 patients, randomized | Telemedicine diagnosis non-inferior to face-to-face for respiratory infections |
| JAMA Network Open, 2024[3] | 27,686 children | PCP telehealth: 28.9% antibiotic rate vs 37.2% for DTC platforms (RR 0.78) |
| JMIR, 2025[4] | Australian GP registrars | Telehealth associated with less antibiotic prescribing for respiratory infections |
| Am J Rhinol Allergy, 2021[6] | 69 CRS patients | Patient satisfaction identical: PSQ-18 scores 78.1 vs 78.4 (P=.67) |
| J Telemed Telecare, 2024[7] | Telemedicine care bundle | Antibiotic prescribing decreased 65% to 56% with embedded clinical pathways |
| AAO-HNSF, 2025[8] | Guidelines update | Watchful waiting now recommended; antibiotic duration shortened to 5–7 days |
What This Means for You
If you've had sinus pressure, congestion, and facial pain for less than 10 days, the most likely diagnosis is a viral sinus infection. A virtual visit can help you determine whether you need antibiotics or whether supportive care — nasal saline rinses, decongestants, pain management — will get you through it. In most cases, the answer is supportive care.
If your symptoms have persisted beyond 10 days without improvement, or if they got better and then suddenly worsened, a virtual visit is still a good first step. Those patterns suggest possible bacterial sinusitis, and a physician can evaluate whether you meet the criteria for antibiotic treatment without you needing to sit in a waiting room.
The 2025 AAO-HNSF guidelines now recommend watchful waiting as the initial approach even for suspected bacterial sinusitis — meaning a 7-day observation period with symptom management before starting antibiotics.[8] That aligns perfectly with telehealth. Your physician can assess your symptoms, recommend supportive care, and schedule a follow-up in a few days to reassess. If you're not improving, antibiotics can be prescribed then. If you are improving, you've avoided an unnecessary prescription entirely.
When antibiotics are indicated, the guidelines now recommend a shorter course: 5–7 days instead of the older 5–10 day range.[8] Amoxicillin with or without clavulanate remains the first-line choice. All of this can be managed through a virtual visit.
When You Still Need an In-Person Visit
Telehealth works well for uncomplicated sinusitis, but certain symptoms warrant hands-on evaluation. In my practice, I redirect patients to in-person or emergency care when I hear any of the following:
- Vision changes — double vision, swelling around the eye, or reduced eye movement (possible orbital complication)
- Severe unilateral facial swelling — suggests spreading infection beyond the sinuses
- Fever above 102°F (39°C) — may indicate a more serious bacterial process
- Neck stiffness or severe headache — raises concern for intracranial extension
- Symptoms worsening despite antibiotics — treatment failure requires re-evaluation and possibly imaging
- Recurrent sinusitis (4+ episodes per year) — suggests an underlying structural or immune problem that needs workup
- Suspected structural problems — nasal polyps, deviated septum, or other anatomic concerns benefit from direct examination
These situations are uncommon. The vast majority of sinus infections — the kind that make you miserable for a week or two but eventually resolve — can be effectively managed through a virtual visit with a physician who knows what to ask and when to escalate.
The evidence is clear: for uncomplicated sinusitis, telehealth doesn't just match in-person care. By multiple measures — guideline adherence, antibiotic stewardship, diagnostic accuracy — it performs better. The visit format isn't the variable that matters. What matters is the physician's clinical judgment, their willingness to follow current guidelines, and their ability to recognize the small number of cases that need something more.
References
- Johnson CF, Balachandran M, Doshi S, et al. "Telehealth versus in-office visits for sinusitis: guideline concordance and antibiotic prescribing." Open Forum Infect Dis. 2019;6(10):ofz393. pmc.ncbi.nlm.nih.gov
- Locke TB, Zhu E, Engel M, et al. "Antibiotic prescribing for acute rhinosinusitis: in-person versus telemedicine." Laryngoscope. 2021;131(12):2610-2615. ohiostate.elsevierpure.com
- Ray KN, et al. "Direct-to-consumer telemedicine tied to more antibiotic prescribing." JAMA Network Open. 2024. cidrap.umn.edu
- "Telehealth associated with less antibiotic prescribing among GP registrars for respiratory infections." JMIR. 2025;27(1):e60831. jmir.org
- "Non-inferiority of telemedicine diagnosis for acute respiratory tract infections: a randomized controlled trial." Einstein Healthcare Network, 2022. pmc.ncbi.nlm.nih.gov
- "Patient satisfaction with telemedicine for chronic rhinosinusitis." Am J Rhinol Allergy. 2021;35(4):528-534. pubmed.ncbi.nlm.nih.gov
- "Telemedicine care bundle for sinusitis: impact on diagnosis coding and antibiotic prescribing." J Telemed Telecare. 2024;30(5). journals.sagepub.com
- AAO-HNSF. "2025 Clinical Practice Guideline Update: Adult Sinusitis." guidelinecentral.com